Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03309878 |
| Title | Mogamulizumab and Pembrolizumab in Treating Patients With Relapsed or Refractory Lymphomas |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | National Cancer Institute (NCI) |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California Davis Comprehensive Cancer Center | Sacramento | California | 95817 | United States | Details | |
| Memorial Sloan Kettering Basking Ridge | Basking Ridge | New Jersey | 07920 | United States | Details | |
| Memorial Sloan Kettering Monmouth | Middletown | New Jersey | 07748 | United States | Details | |
| Memorial Sloan Kettering Bergen | Montvale | New Jersey | 07645 | United States | Details | |
| Memorial Sloan Kettering Commack | Commack | New York | 11725 | United States | Details | |
| Memorial Sloan Kettering Westchester | Harrison | New York | 10604 | United States | Details | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| Memorial Sloan Kettering Nassau | Uniondale | New York | 11553 | United States | Details |